Track the 제테마 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 제테마 has published 16 insider filings. Market capitalisation: €188.3bn. The latest transaction was reported on 1 September 2026 (Purchase). Among the most active insiders: 조상준. The full history is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€2,935
6 ops.
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
Buys €2,935n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,225 of 29,057 companies
25.1
score / 100
Value
22
Quality
28
FCF yld-2.5%
Earn yld-3.5%
EV/EBITDA26.7x
ROE-2.6%
Gross mgn48%
Net mgn-8.6%
Debt/EBITDA10.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
제테마 is a healthcare and pharmaceutical company listed on the XKRX. It specializes in the development and marketing of pharmaceutical and healthcare products.